My title
» General Medicine

General Medicine

GENERAL MEDICINE CLINICAL TRIALS

 

Clostridium difficile
Study Link Study Status Study Title Principal Investigator
SER-262 Active SER-262 Versus Placebo in Adults with Primary Clostridium Difficile Infection to Prevent Recurrence PI: James Welker
Crestovo-CP101 Active Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects with Recurrent Clostridium Difficile PI: James Welker
Adult RSV
Study Link Study Status Study Title Principal Investigator
GS-US-218-1227 Active A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hospitalized Adults with Respiratory Syncytial Virus (RSV) Infection PI: James Welker
Acute Major Bleeding
Study Link Study Status Study Title Principal Investigator
ANNEXA Active PROSPECTIVE, OPEN-LABEL STUDY OF ANDEXANET ALFA IN PATIENTS RECEIVING A FACTOR XA INHIBITOR WHO HAVE ACUTE MAJOR BLEEDING PI: James Welker
Staphylococcus aureus
Study Link Study Status Study Title Principal Investigator
Theravance 0112 Active A Phase 3 Multicenter, Randomized, Open-label, Clinical Trial of Telavancin Versus Standard Intravenous Therapy in the Treatment of Subjects with Staphylococcus aureus Bacteremia Including Infective Endocarditis PI: James Welker
Acute Kidney Injury
Study Link Study Status Study Title Principal Investigator
STOP-AKI Active A Safety, Tolerability, Efficacy, and QOL Study of Human Recombinant Alkaline Phosphatase (recap) in the Treatment of Patients with Sepsis Associated Acute Kidney Injury PI: James Welker

 

Our Studies